Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Diemunsch

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Breast Cancer Research and Treatment|January 7, 2011
Paraneoplastic polymyositis associated with breast cancer: a therapeutic emergencyS Croce, M Guèye, A C E Korganow, et al.
Journal of Clinical Anesthesia|August 1, 1997
Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgeryP Diemunsch, A D'Hollander, L Paxton, et al.
British Journal of Anaesthesia|June 12, 1999
Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgeryP Diemunsch, P Schoeffler, B Bryssine, et al.
British Journal of Anaesthesia|April 1, 1996
Single-dose i.v. granisetron in the prevention of postoperative nausea and vomitingA J Wilson, P Diemunsch, B G Lindeque, et al.
Contraception, Fertilite, Sexualite (1992)|May 1, 1997
[Urinary complications during laparoscopy: a urachal diverticula injury]J C Darmon, L Chevallier, P Diemunsch, et al.
Journal of Clinical Anesthesia|April 25, 2000
Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study GroupB K Philip, C H McLeskey, J E Chelly, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1989
[Glanzmann's thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled cesarean section]M Vivier, A Treisser, M Naett, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 19, 2012
Methylene blue protects liver oxidative capacity after gut ischaemia-reperfusion in the ratO Collange, A-L Charles, J Bouitbir, et al.
Journal of Clinical Anesthesia|April 3, 1998
Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study GroupP Diemunsch, K Korttila, J Leeser, et al.
The British Journal of Surgery|January 29, 2015
Intraoperative fluorescence-based enhanced reality laparoscopic real-time imaging to assess bowel perfusion at the anastomotic site in an experimental modelM Diana, V Agnus, P Halvax, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|January 7, 2011
Paraneoplastic polymyositis associated with breast cancer: a therapeutic emergencyS Croce, M Guèye, A C E Korganow, et al.
Journal of Clinical Anesthesia|August 1, 1997
Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgeryP Diemunsch, A D'Hollander, L Paxton, et al.
British Journal of Anaesthesia|June 12, 1999
Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgeryP Diemunsch, P Schoeffler, B Bryssine, et al.
British Journal of Anaesthesia|April 1, 1996
Single-dose i.v. granisetron in the prevention of postoperative nausea and vomitingA J Wilson, P Diemunsch, B G Lindeque, et al.
Contraception, Fertilite, Sexualite (1992)|May 1, 1997
[Urinary complications during laparoscopy: a urachal diverticula injury]J C Darmon, L Chevallier, P Diemunsch, et al.
Journal of Clinical Anesthesia|April 25, 2000
Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study GroupB K Philip, C H McLeskey, J E Chelly, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1989
[Glanzmann's thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled cesarean section]M Vivier, A Treisser, M Naett, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 19, 2012
Methylene blue protects liver oxidative capacity after gut ischaemia-reperfusion in the ratO Collange, A-L Charles, J Bouitbir, et al.
Journal of Clinical Anesthesia|April 3, 1998
Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study GroupP Diemunsch, K Korttila, J Leeser, et al.
The British Journal of Surgery|January 29, 2015
Intraoperative fluorescence-based enhanced reality laparoscopic real-time imaging to assess bowel perfusion at the anastomotic site in an experimental modelM Diana, V Agnus, P Halvax, et al.
Pageof 7